Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Propanc Biopharma Inc (PPCB)

Propanc Biopharma Inc (PPCB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,956
  • Shares Outstanding, K 434,706
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,040 K
  • 60-Month Beta 4.21
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/06/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0059 +15.25%
on 05/23/19
0.0095 -28.42%
on 06/12/19
-0.0002 (-2.86%)
since 05/21/19
3-Month
0.0059 +15.25%
on 05/23/19
0.0151 -54.97%
on 03/25/19
-0.0048 (-41.38%)
since 03/21/19
52-Week
0.0039 +74.36%
on 08/27/18
0.2888 -97.65%
on 09/05/18
-0.0551 (-89.01%)
since 06/21/18

Most Recent Stories

More News
Propanc Biopharma Appoints Carlo Campiciano as Chief Financial Officer

Propanc Biopharma, Inc. (OTC: PPCB) ("Propanc", the "Company", "we", "our", or "us"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer,...

PPCB : 0.0068 (-9.33%)
Propanc Biopharma Appoints Dr. Ralf Brandt to its Scientific Advisory Board

Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced...

PPCB : 0.0068 (-9.33%)
CGIX : 0.17 (unch)
Propanc Biopharma Initiates Development of Bio-Analytical Assay in Preparation for Human Trials

Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that it has...

PPCB : 0.0068 (-9.33%)
Propanc Biopharma Initiates Development of Bio-Analytical Assay in Preparation for Human Trials

MELBOURNE, Australia , March 25, 2019 /PRNewswire/ --  Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering...

PPCB : 0.0068 (-9.33%)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

EVLLF : 0.7600 (+0.33%)
TRLFF : 0.2845 (-4.59%)
AITB : 5.16 (-0.77%)
BICXD : 4.5400 (-9.02%)
MMNFF : 2.4400 (+2.09%)
ATEA : 5.9600 (+3.11%)
CWBHF : 13.6700 (+3.95%)
CVSI : 3.9300 (-0.72%)
DUOT : 0.8000 (+1.27%)
CRLBF : 10.6480 (-0.10%)
ARREF : 0.5245 (+0.87%)
CLOK : 0.9479 (-0.21%)
MLCPF : 3.5200 (+11.47%)
CNBX : 0.2700 (-0.37%)
HEOFF : 0.8548 (-8.49%)
MJARF : 1.1580 (+8.45%)
ALEAF : 0.9250 (+25.51%)
OTCM : 31.8600 (-8.58%)
NUPMF : 1.8400 (-0.54%)
GLDLF : 0.6973 (-4.48%)
NMUS : 0.6500 (-9.52%)
NLST : 0.3290 (-0.30%)
GBPT : 0.3000 (+5.93%)
IMLFF : 0.2671 (-3.75%)
KSHB : 4.6250 (+4.99%)
CORVF : 1.7000 (+1.19%)
ELLXF : 2.5300 (+1.61%)
RSSS : 2.4000 (+0.42%)
ISYRF : 0.9150 (+4.21%)
FLUX : 1.0300 (+3.00%)
NWGI : 0.3200 (+6.35%)
QBIO : 1.5300 (unch)
WIZD : 0.1800 (+12.50%)
MRMD : 2.1200 (-0.93%)
GRWG : 3.2600 (+7.24%)
BRTI : 0.1100 (-24.19%)
GTBP : 0.2500 (-3.81%)
MRIC : 3.1000 (unch)
DYAI : 6.00 (+2.92%)
GTBIF : 11.1400 (+6.85%)
MTAFF : 0.7900 (-2.84%)
EMHTF : 1.7700 (-1.67%)
ITHUF : 3.1620 (-0.31%)
ALYE : 4.0000 (+14.29%)
VTLR : 0.1411 (+14.62%)
ARHH : 1.2000 (-4.76%)
OWCP : 0.0159 (-6.47%)
STLHF : 0.6690 (+1.03%)
PPCB : 0.0068 (-9.33%)
ARTH : 0.3200 (+10.34%)
ACRGF : 16.9715 (-0.28%)
Propanc Biopharma Receives Notice of Allowance for Additional Claims from Foundation Patent in the U.S.

Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that it has...

PPCB : 0.0068 (-9.33%)
Propanc Biopharma to Present at the 31st Annual ROTH Conference March 17 - 19, 2019

Propanc Biopharma, Inc. (OTCQB:PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced...

PPCB : 0.0068 (-9.33%)
Propanc Biopharma to Present at the 2019 BIO CEO & Investor Conference

Propanc Biopharma, Inc. (OTCQB: PPCB) ("Propanc"), a clinical stage biopharmaceutical company focused on development of new and proprietary treatments for cancer patients suffering...

PPCB : 0.0068 (-9.33%)
Fighting Cancer at the Root: VeraStem and Propanc Biopharma

TORONTO, ON / ACCESSWIRE / January 23, 2019 / The Wealthy Venture Capitalist (or "WVC"), an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known...

CELG : 92.41 (-0.84%)
OMED : 0.93 (+4.49%)
PPCB : 0.0068 (-9.33%)
BAYN : 0.0147 (+33.64%)
BLCM : 1.85 (-8.42%)
INO : 3.02 (+19.84%)
VSTM : 1.59 (-7.56%)
CLLS : 15.07 (+1.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade PPCB with:

Key Turning Points

2nd Resistance Point 0.0079
1st Resistance Point 0.0073
Last Price 0.0068
1st Support Level 0.0064
2nd Support Level 0.0061

See More

52-Week High 0.2888
Fibonacci 61.8% 0.1800
Fibonacci 50% 0.1463
Fibonacci 38.2% 0.1127
Last Price 0.0068
52-Week Low 0.0039

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar